OPKO Health
OPK
#5858
Rank
ยฃ0.79 B
Marketcap
ยฃ1.01
Share price
-0.74%
Change (1 day)
-19.41%
Change (1 year)

Revenue for OPKO Health (OPK)

Revenue in 2025 (TTM): ยฃ0.48 Billion

According to OPKO Health 's latest financial reports the company's current revenue (TTM ) is ยฃ0.48 Billion. In 2024 the company made a revenue of ยฃ0.56 Billion a decrease over the revenue in the year 2023 that were of ยฃ0.67 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for OPKO Health from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.48 B-13.88%
2024 ยฃ0.56 B-16.16%
2023 ยฃ0.67 B-18.34%
2022 ยฃ0.83 B-36.87%
2021 ยฃ1.31 B24.85%
2020 ยฃ1.05 B53.1%
2019 ยฃ0.68 B-11.83%
2018 ยฃ0.78 B5.57%
2017 ยฃ0.73 B-25.36%
2016 ยฃ0.99 B198.37%
2015 ยฃ0.33 B466.94%
2014 ยฃ58.52 M0.02%
2013 ยฃ58.52 M101.06%
2012 ยฃ29.1 M61.69%
2011 ยฃ18 M-20.51%
2010 ยฃ22.64 M178.74%
2009 ยฃ8.12 M26.14%
2008 ยฃ6.44 M
2001 ยฃ0.91 M58.63%
2000 ยฃ0.57 M-29.32%
1999 ยฃ0.82 M4.89%
1998 ยฃ0.78 M328.09%
1997 ยฃ0.18 M4.24%
1996 ยฃ0.17 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
ยฃ69.11 B 14,251.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ32.88 B 6,728.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ10.68 B 2,119.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ12.58 B 2,512.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Alnylam Pharmaceuticals
ALNY
ยฃ2.40 B 399.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ36.02 B 7,381.16%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ10.32 B 2,043.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
ยฃ0.29 B-37.98%๐Ÿ‡บ๐Ÿ‡ธ USA